Attached files

file filename
10-K - FORM 10-K - Sierra Oncology, Inc.d522898d10k.htm
EX-32.1 - EX-32.1 - Sierra Oncology, Inc.d522898dex321.htm
EX-31.2 - EX-31.2 - Sierra Oncology, Inc.d522898dex312.htm
EX-31.1 - EX-31.1 - Sierra Oncology, Inc.d522898dex311.htm
EX-23.1 - EX-23.1 - Sierra Oncology, Inc.d522898dex231.htm
EX-21.1 - EX-21.1 - Sierra Oncology, Inc.d522898dex211.htm

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Sukhi Jagpal, Chief Financial Officer of Sierra Oncology, Inc. (Company), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

    the Annual Report on Form 10-K of the Company for the year ended December 31, 2017 (Report), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date: February 27, 2018

 

/s/ Sukhi Jagpal

 

Sukhi Jagpal

Chief Financial Officer

(Principal Financial Officer)